Matrix metalloproteinase-14
Also known as: MMP14
Function
Endopeptidase that degrades various components of the extracellular matrix such as collagen. Essential for pericellular collagenolysis and modeling of skeletal and extraskeletal connective tissues during development (By similarity). Activates progelatinase A/MMP2, thereby acting as a positive regulator of cell growth and migration. Involved in the formation of the fibrovascular tissues in association with pro-MMP2. May be involved in actin cytoskeleton reorganization by cleaving PTK7. Acts as a regulator of Notch signaling by mediating cleavage and inhibition of DLL1. Cleaves ADGRB1 to release vasculostatin-40 which inhibits angiogenesis. Acts as a negative regulator of the GDF15-GFRAL aversive response by mediating cleavage and inactivation of GFRAL.
Classification
- Family (Pfam)
- PF11857 DUF3377, PF00045 Hemopexin, PF00413 Peptidase_M10, PF01471 PG_binding_1
- InterPro
- Hemopexin-like_dom, Hemopexin-like_dom_sf, Hemopexin-like_repeat, Hemopexin_CS, M10A_MMP, MetalloPept_cat_dom_sf, Pept_M10_metallopeptidase, Pept_M10A, Pept_M10A_metallopeptidase_C, Pept_M10A_Zn_BS, Peptidase_Metallo, Peptidoglycan-bd-like, PGBD-like_sf, PGBDSf
- Functional cluster
- Venom Serine Proteases & Phospholipase A2
Experimental structures · PDB · 12
- 1BQQ X-ray 2.75A
- 1BUV X-ray 2.75A
- 2MQS NMR
- 3C7X X-ray 1.70A
- 3MA2 X-ray 2.05A
- 3X23 X-ray 2.40A
- 4P3C X-ray 1.94A
- 4P3D X-ray 1.95A
- 4QXU X-ray 2.30A
- 5H0U X-ray 2.24A
- 6CLZ NMR
- 6CM1 NMR
A predicted model is available from AlphaFold.
Gene Ontology · 48
- GO:0031410 cytoplasmic vesicle
- GO:0031012 extracellular matrix
- GO:0005615 extracellular space
- GO:0005925 focal adhesion
- GO:0005796 Golgi lumen
- GO:0044354 macropinosome
- GO:0042470 melanosome
- GO:0005634 nucleus
- GO:0005886 plasma membrane
- GO:0004175 endopeptidase activity
- GO:0005178 integrin binding
- GO:0070006 metalloaminopeptidase activity
- GO:0004222 metalloendopeptidase activity
- GO:0004252 serine-type endopeptidase activity
- GO:0008270 zinc ion binding
- GO:0001525 angiogenesis
- GO:0043615 astrocyte cell migration
- GO:0048870 cell motility
- GO:0071412 cellular response to genistein
- GO:0030574 collagen catabolic process
- GO:0035987 endodermal cell differentiation
- GO:0001935 endothelial cell proliferation
- GO:0022617 extracellular matrix disassembly
- GO:0030198 extracellular matrix organization
- GO:0008584 male gonad development
- GO:0051895 negative regulation of focal adhesion assembly
- GO:0160145 negative regulation of GDF15-GFRAL signaling pathway
- GO:0045746 negative regulation of Notch signaling pathway
- GO:0001503 ossification
- GO:0001541 ovarian follicle development
- GO:0045579 positive regulation of B cell differentiation
- GO:0030307 positive regulation of cell growth
- GO:0030335 positive regulation of cell migration
- GO:1905523 positive regulation of macrophage migration
- GO:0010831 positive regulation of myotube differentiation
- GO:0010954 positive regulation of protein processing
- GO:0030163 protein catabolic process
- GO:0016485 protein processing
- GO:0006508 proteolysis
- GO:1903076 regulation of protein localization to plasma membrane
- GO:0043627 response to estrogen
- GO:0001666 response to hypoxia
- GO:0009612 response to mechanical stimulus
- GO:1990834 response to odorant
- GO:0006979 response to oxidative stress
- GO:0001501 skeletal system development
- GO:0048771 tissue remodeling
- GO:0031638 zymogen activation
Disease associations
- Winchester syndrome MONDO:0010201
Drugs targeting this protein · 2
- CTS-1027 inhibitor
- REBIMASTAT inhibitor
Related proteins · sequence + function similarity
- Matrix metalloproteinase-14 1.00
- Matrix metalloproteinase-14 1.00
- Matrix metalloproteinase-14 1.00
- Matrix metalloproteinase-14 0.99
- Matrix metalloproteinase-14 0.99
- Matrix metalloproteinase-14 0.99
- Matrix metalloproteinase-24 0.95
- Matrix metalloproteinase-24 0.95
- Matrix metalloproteinase-15 0.94
- Matrix metalloproteinase-24 0.93
- Matrix metalloproteinase-15 0.93
- Interstitial collagenase 0.90
Co-cited proteins · studied together in the literature
- Matrix metalloproteinase-15 1 shared papers
- Matrix metalloproteinase-14 2 shared papers
- Inactive tyrosine-protein kinase 7 1 shared papers
- Delta-like protein 1 1 shared papers
- Matrix metalloproteinase-14 1 shared papers
- Metalloproteinase inhibitor 2 1 shared papers
- Nanos homolog 1 1 shared papers
- 72 kDa type IV collagenase 1 shared papers
- Adhesion G protein-coupled receptor B1 1 shared papers
- Bone marrow stromal antigen 2 1 shared papers
- GDNF family receptor alpha-like 1 shared papers
- Laminin subunit alpha-1 1 shared papers
Literature · 20 cited papers
- Body weight regulation via MT1-MMP-mediated cleavage of GFRAL. Nat. Metab. · 2022
- A secreted tyrosine kinase acts in the extracellular environment. Cell · 2014
- Mutation of membrane type-1 metalloproteinase, MT1-MMP, causes the multicentric osteolysis and arthritis disease Winchester syndrome. Am. J. Hum. Genet. · 2012
- A proprotein convertase/MMP-14 proteolytic cascade releases a novel 40 kDa vasculostatin from tumor suppressor BAI1. Oncogene · 2012
- BST-2 binding with cellular MT1-MMP blocks cell growth and migration via decreasing MMP2 activity. J. Cell. Biochem. · 2012
- MT1-MMP cleaves Dll1 to negatively regulate Notch signalling to maintain normal B-cell development. EMBO J. · 2011
- The Wnt/planar cell polarity protein-tyrosine kinase-7 (PTK7) is a highly efficient proteolytic target of membrane type-1 matrix metalloproteinase: implications in cancer and embryogenesis. J. Biol. Chem. · 2010
- The E-cadherin-repressed hNanos1 gene induces tumor cell invasion by upregulating MT1-MMP expression. Oncogene · 2008
- Proteomic and bioinformatic characterization of the biogenesis and function of melanosomes. J. Proteome Res. · 2006
- The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. · 2004
- Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat. Genet. · 2004
- Production and activation of matrix metalloproteinase-2 in proliferative diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. · 2003
- … and 8 more in the literature graph